• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2025, Vol. 27 ›› Issue (6): 859-866.DOI: 10.3969/j.issn.1671-2587.2025.06.019

Previous Articles     Next Articles

The Role of Nucleated Red Blood Cells in Diagnosis and Prognosis

ZHU Yuanyuan, PENG Fang, LI Ning   

  1. Department of Blood Transfusion, National Health Commission Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, Changsha 410008
  • Received:2025-05-26 Published:2025-12-24

Abstract: Nucleated red blood cells (NRBCs) are immature precursors of red blood cells that retain their nuclei during the process of erythropoiesis. Under physiological conditions, NRBCs are predominantly present in the peripheral blood of pregnant women and neonates, while they are rarely detected in healthy adults. However, their levels in peripheral blood increase significantly under various pathological conditions, including hematological disorders, infectious diseases, and malignancies. This elevation is closely associated with adverse clinical outcomes, making NRBCs promising candidates as diagnostic biomarkers and prognostic indicators. This article aims to provide a comprehensive review of recent advances in NRBC research, with a focus on their molecular mechanisms in disease progression, as well as their potential applications in clinical diagnosis, treatment monitoring, and prognosis evaluation, thereby offering a new insight and strategy for precision medicine.

Key words: Nucleated red blood cells, Biomarkers, Disease diagnosis, Prognosis assessment

CLC Number: